Latest News - CRSTodayEurope

Monday, April 17, 2017 | Management/Leadership, Katena Products

Katena Products Announces Mark Fletcher as CEO

Katena Products has announced the appointment of Mark J. Fletcher as their new President and CEO, effective March 1, 2017. Prior to joining Katena, Mr. Fletcher was President of the Surgical Technolog…

Read the full story

Monday, April 17, 2017 | Cornea, Medical Studies

Stanford Lab Grows Cornea Cells for Transplant

A Stanford research team has created a potentially powerful new way to fix damaged corneas -- a major source of vision problems and blindness. Millions of new eye cells are being grown in a Palo Alt…

Read the full story

Monday, April 17, 2017 | Product Releases, Nidek

Nidek launches the NAVEX Quest M2 Nidek Advanced Vision Excimer Laser System

Nidek has announced the launch of the NAVEX Quest M2 Nidek Advanced Vision Excimer Laser System, which incorporates the Quest M2 excimer laser system, the OPD-Scan III whole eye aberrometer and cornea…

Read the full story

Friday, April 14, 2017 | Management/Leadership

In Memory of Dr. Richard C. Troutman, ISRS Co-Founder, Innovator, Gifted Clinician

The ISRS community mourns the passing of Richard C. Troutman, MD, DSC, one of the most significant pioneers in the field of refractive surgery, and co-founder of the society now known as the Internati…

Read the full story

Thursday, April 13, 2017 | Product Releases, Keeler Instruments

New Digital Applanation Tonometer from Keeler

Keeler has expanded its range of tonometers with the D-KAT Z-type, the first digital applanation tonometer designed for Keeler Z Series Slit Lamps and other lower illumination style slit lamps, accord…

Read the full story

Thursday, April 13, 2017 | Acquisitions/Mergers, Glaucoma, Glaukos Corporation, MIGS

Glaukos Corporation Acquires IOP Sensor System from DOSE Medical

Glaukos announced that it has acquired the IOP sensor system assets and related liabilities from DOSE Medical Corporation for $5.5 million in cash, plus performance-based consideration of up to $9.5 m…

Read the full story

Thursday, April 13, 2017 | Glaucoma, MIGS

Sight Sciences Announces Health Canada Approval of the VISCO360 Viscosurgical System for Standalone Microinvasive Glaucoma Surgery (MIGS)

Sight Sciences announced that it has received Health Canada approval for the VISCO360 Viscosurgical System. The VISCO360 System is indicated in Canada for the microcatheterization and transluminal vis…

Read the full story

Wednesday, April 12, 2017 | Clinical Trials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Reports Positive 6-Month Topline Safety and Efficacy Results for Rhopressa 0.02%

Aerie Pharmaceuticals reported the successful 6-month topline safety and efficacy results of its Rocket 4 phase 3 clinical trial for product candidate Rhopressa, a novel once-daily eye drop being test…

Read the full story

Wednesday, April 12, 2017 | Partnerships, Novartis

Commentary: Novartis Finds Its Next Mass-Market Ophthalmology Drug Candidate at a Small Virtual Biotech With a Global View

Like me, you may never have heard about Lubris BioPharma before today. But Novartis has. And that is by far more important. Today the pharma giant reached out and exercised an option on a recombinant …

Read the full story

Wednesday, April 12, 2017 | Medical Studies

Intensive Glucose Control Lowers Microvascular Risks

Intensive glucose lowering in patients with type 2 diabetes significantly reduces the risk for microvascular kidney and eye complications over the longer term, according to the results of an individua…

Read the full story

Tuesday, April 11, 2017 | Clinical Trials, Nicox

Nicox Announces PDUFA Date for Allergic Conjunctivitis Drug Candidate Zerviate

Nicox announced that the FDA has set a PDUFA date of September 8, 2017 for its decision on the new drug application (NDA) for Zerviate (cetirizine ophthalmic solution) 0.24%, Nicox's novel, propri…

Read the full story

Tuesday, April 11, 2017 | Clinical Trials

Eyevensys Receives Approval From the French Product Security Regulatory Agency ANSM to Advance its EyeCET Platform Into Clinical Development

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, announced it has received approval from the French product security regulatory agency 'Agence Nationale de S&…

Read the full story

Tuesday, April 11, 2017 | Clinical Trials, Inotek Pharmaceuticals

Inotek Completes Patient Recruitment in Phase 2 Trial of a Fixed-Dose Combination of Trabodenoson and Latanoprost

Inotek Pharmaceuticals announced the completion of the active recruitment phase of the phase 2 dose-ranging trial of a fixed-dose combination (FDC) of trabodenoson and latanoprost for the treatment of…

Read the full story

Monday, April 10, 2017 | Acquisitions/Mergers

Cutting Edge Group SAS Acquires Kestrel Ophthalmics

Cutting Edge SAS announced it has signed a definitive agreement to acquire Kestrel Ophthalmics Limited, an ophthalmic distributor in the United Kingdom. Terms of the deal were not disclosed. Kes…

Read the full story

Monday, April 10, 2017 | Awards

Children's Hospital of Philadelphia Ophthalmologist Honored With the 2017 American Association for Pediatric Ophthalmology and Strabismus Young Investigator Award

Gil Binenbaum, MD, a pediatric eye surgeon in the Division of Ophthalmology at Children's Hospital of Philadelphia (CHOP), has received the 2017 American Association for Pediatric Ophthalmology an…

Read the full story
Load More